surgery plan News
-
HipXpert Now Supports DePuy Synthes’ PINNACLE
Surgical Planning Associates, Inc. announces a new HipXpert software release that now includes the addition of DePuy Synthes’ PINNACLE® Acetabular Cup System and the ACTIS®, CORAIL®, SUMMIT®, and TRI-LOCK® Hip Systems to our patient-specific surgery planning and navigation system. HipXpert’s open-platform, 3D surgery planning software now supports more than 20 ...
By HipXpert
-
Golden Valley Memorial Healthcare is First Hospital in Missouri to Perform Total Knee Replacement Procedures with THINK Surgical’s Next-Generation Robot System
THINK Surgical, Inc., a leading innovator in the field of orthopedic robotic surgery, announced that Golden Valley Memorial Healthcare (GVMH) in Clinton, MO is among the first healthcare facilities to employ the second-generation TSolution One® robot for total knee arthroplasty (TKA). James Womack, M.D., a board-certified orthopedic surgeon and fellow of the American Association of Hip and ...
-
Planmeca and Navigate Surgical Technologies Join Forces to Launch Innovative Solutions for Dental Im
Dental manufacturer Planmeca and Navigate Surgical Technologies (NST), a provider of real-time surgical navigation solutions, are pleased to announce their cooperation. This partnership aims to provide dental implant surgeons with technological innovations that will deliver enhanced patient outcomes through improved accuracy and precision, as well as through simplified digital workflows. Dynamic ...
-
HTG Used for First Time in Congenital Heart Defect Surgery
It was another first for EchoPixel when its Holographic Therapy Guidance (HTG) was used in a congenital heart surgery at Cincinnati Children’s Hospital Medical Center. The procedure was conducted with a new mini 4D transesophageal echocardiography (TEE), which generates real-time ultrasound images and can be used in patients as small as 11 pounds. A life-saving procedure Complete ...
-
EM Imaging obtains global licence for optical agent that detects cancer early
Edinburgh Molecular Imaging Ltd. (EM Imaging) has signed an exclusive global license for a novel optical imaging agent that could improve the detection of early-stage colorectal (bowel) cancer. EM Imaging, a company which develops and commercialises novel optical imaging agents, recently signed the licensing agreement with GE Healthcare Ltd. and Dyax Inc. EM Imaging will now complete the ...
-
Interview with Dr. Ricardo Henriques, Master Clinical Trainer
What is the current status of new technologies in the surgical phase of dental implantology? Researchers and clinicians are increasingly aware of the factors that ensure positive treatment outcomes in implant rehabilitation of the dentition. Innovative software merged with cbCT data sets provides the means to plan the position and angulation of virtual implants. 3D printing or milling ...
By ClaroNav
-
Hydrus Microstent Receives Highest Designation of Any MIGS Device as Part of AAO Treatment Guidelines
Ivantis Inc., developer of the novel Hydrus® Microstent, a minimally invasive glaucoma surgery (MIGS) device intended to lower eye pressure for open-angle glaucoma patients, announced today that the American Academy of Ophthalmology (AAO) has designated the Hydrus Microstent as “Level 1, Moderate Quality, Strong Recommendation” — the highest designation of any MIGS device ...
-
Hydrus Microstent Now First MIGS Device Proven With 5-Year Pivotal Trial Data; Results Show Over 60% Reduction in Secondary Glaucoma Surgeries, Sustained Reduction in Medication Use
Ivantis Inc., developer of the novel Hydrus® Microstent, a minimally invasive glaucoma surgery (MIGS) device designed to lower eye pressure for open-angle glaucoma patients, announced today the first-ever release of five-year follow-up data from its HORIZON pivotal trial. This significant milestone represents the longest continuous follow-up of a MIGS device pivotal trial and comes on the ...
-
Hackensack University Medical Center is the First Hospital on the East Coast to Perform Total Knee Replacement Procedures with THINK Surgical’s Next-Generation Robot System
Hackensack University Medical Center, a national leader in orthopedic care and robotic surgery, recently completed the first total knee replacement on the East Coast using the newest generation of the TSolution One robot from THINK Surgical. The system, manufactured by the Fremont, CA – based company features a true, active robot which supports a choice of knee implants from multiple ...
-
France: eCential Robotics and EIB announce €15million in financing for research and innovation in digital and robotics for neuro-musculo-skeletal surgery
Gières (Grenoble), France, December, 14 2021 The funds will enable eCential Robotics to invest in research and development to offer a fully unified and comprehensive robotic solution for less invasive surgical procedures, assisting surgeons from planning through to execution. The operation comes under secured global financing of close to €100 million in equity, quasi-equity ...
-
Centennial Hills Hospital Medical Center is the First Hospital in the Western United States to Perform a Total Knee Replacement Procedure with THINK Surgical’s Leading Robot System
THINK Surgical, Inc., an innovator in the field of orthopedic robotic surgery, proudly announced Centennial Hills Hospital Medical Center became the first facility in the western United States to utilize the latest iteration of the TSolution One robot from THINK Surgical. The system, manufactured by the Fremont, CA – based company features a true, active robot which supports a choice of ...
-
Pixee Medical obtained the 510(k)
Pixee Medical is proud to announce that its Knee+ AR Computer Assisted Orthopedic solution received 510(k) clearance from the US Food and Drug Administration. Following a CE mark and first worldwide augmented Total Knee Arthroplasty surgery last year, the approval is opening the US market and will accelerate the excellent sales momentum observed in Europe and Australia since January. Pixee ...
-
Asensus Surgical, Inc. Schedules Fourth Quarter and Fiscal Year 2020 Financial and Operating Results Conference Call for March 11, 2021
Asensus Surgical, Inc. (NYSE American: TRXC) (formerly TransEnterix, Inc.), a medical device company that is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided Surgery™, announced today that it plans to release fourth quarter and fiscal year 2020 financial and operating results after the market closes on Thursday, March 11, 2021. The Company ...
-
Asensus Surgical, Inc. Schedules Third Quarter Financial and Operating Results Conference Call for November 3, 2021
Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided Surgery™, announced today that it plans to release 2021 third quarter financial and operating results after the market closes on Wednesday, November 3, 2021. The Company will host a conference call to discuss ...
-
Memic Receives FDA De Novo Marketing Authorization for First-Ever Surgical Robotic System with Humanoid-shaped Robotic Arms
Memic, a medical device company dedicated to transforming robot-assisted surgery with its proprietary technology, today announced that the U.S. Food and Drug Administration (FDA) has granted De Novo marketing authorization of its Hominis® robot-assisted surgical platform for use in single site, natural orifice laparoscopic-assisted transvaginal benign surgical procedures including benign ...
-
Former Professional Baseball Player Pain-Free after Knee Surgery with Active Robot Technology Available at INOV8 Surgical
THINK Surgical, Inc., an innovator in the field of orthopedic active robot surgery, is pleased to announce that Stefan Kreuzer, M.D.*, of INOV8 Surgical, a leading ambulatory surgical center (ASC) in Houston specializing in outpatient total joint procedures, is approaching a key milestone with THINK’s active robot technology. Dr. Kreuzer has performed nearly 90 procedures** with the ...
-
Palisade Bio (Nasdaq: PALI) Announces Analysis Demonstrating LB1148 Reduced The Extent And Severity Of Post-Surgical Intraabdominal Adhesions By 93%
Data from Pooled-Analysis of Enteral Protease Inhibitor LB1148 Demonstrated 72% Reduction in the Risk of Adhesion Formation in Patients Undergoing Bowel Resection Surgery Company to Host Conference Call on Wednesday, March 16, 2022, at 8:30 a.m. EST Palisade Bio, Inc. (Nasdaq: PALI), a clinical stage biopharmaceutical company advancing therapies for acute and chronic gastrointestinal (GI) ...
By Palisade Bio
-
First-Ever Four-Year MIGS Pivotal Trial Results Show Hydrus Microstent Significantly Reduces Need for Invasive Surgery and Subsequent Glaucoma Medication
Ivantis, Inc., developer of the novel Hydrus® Microstent, a minimally invasive glaucoma surgery (MIGS) device designed to lower eye pressure for open-angle glaucoma patients, announced today the first-ever, four-year follow-up data for a MIGS device in an FDA pivotal trial. The latest findings from the HORIZON study confirm the benefits of the Hydrus Microstent seen in earlier follow-up and ...
-
A Brand New Collaboration Between Emovi and The Geneva Foundation
In partnership with The Geneva Foundation and supporting grant from the Quebec Ministry of Economy and Innovation, Emovi will launch the 24-month clinical project within US Army clinics at Fort Bragg and High Point University, North Carolina, USA Emovi, Inc., a leading medical device developer and manufacturer for orthopaedics, announced today a clinical collaboration with the US Army in ...
By Emovi
-
Nubeqa (darolutamide) approved for additional prostate cancer indication in China
Nubeqa now approved for metastatic hormone-sensitive prostate cancer as well as non-metastatic castration-resistant prostate cancer Additional indication based on data from the pivotal Phase III ARASENS trial The Chinese National Medical Products Administration (NMPA) has approved the oral androgen receptor inhibitor (ARi) Nubeqa™ (darolutamide) in combination with docetaxel for the ...
By Bayer AG
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you